Follow
Peter J.M. Valk
Peter J.M. Valk
Erasmus University Medical Center
Verified email at erasmusmc.nl
Title
Cited by
Cited by
Year
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation
ME Figueroa, O Abdel-Wahab, C Lu, PS Ward, J Patel, A Shih, Y Li, ...
Cancer cell 18 (6), 553-567, 2010
30542010
Prognostically useful gene-expression profiles in acute myeloid leukemia
PJM Valk, RGW Verhaak, MA Beijen, CAJ Erpelinck, ...
New England Journal of Medicine 350 (16), 1617-1628, 2004
14652004
DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia
ME Figueroa, S Lugthart, Y Li, C Erpelinck-Verschueren, X Deng, ...
Cancer cell 17 (1), 13-27, 2010
9682010
Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression …
RGW Verhaak, CS Goudswaard, W Van Putten, MA Bijl, MA Sanders, ...
Blood 106 (12), 3747-3754, 2005
7962005
A 17-gene stemness score for rapid determination of risk in acute leukaemia
SWK Ng, A Mitchell, JA Kennedy, WC Chen, J McLeod, N Ibrahimova, ...
Nature 540 (7633), 433-437, 2016
7732016
Molecular minimal residual disease in acute myeloid leukemia
M Jongen-Lavrencic, T Grob, D Hanekamp, FG Kavelaars, A Al Hinai, ...
New England Journal of Medicine 378 (13), 1189-1199, 2018
7522018
Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely …
BJ Wouters, B Löwenberg, CAJ Erpelinck-Verschueren, WLJ van Putten, ...
Blood, The Journal of the American Society of Hematology 113 (13), 3088-3091, 2009
7112009
A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia
S Gröschel, MA Sanders, R Hoogenboezem, E de Wit, BAM Bouwman, ...
Cell 157 (2), 369-381, 2014
7012014
Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia
PJ Valk, RG Verhaak, MA Beijen, CA Erpelinck
N Engl J Med 350 (16), 1617-28, 2004
630*2004
High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study
M Terwijn, WLJ van Putten, A Kelder, VHJ van der Velden, RA Brooimans, ...
Journal of clinical oncology 31 (31), 3889-3897, 2013
5222013
MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia
M Jongen-Lavrencic, SM Sun, MK Dijkstra, PJM Valk, B Löwenberg
Blood, The Journal of the American Society of Hematology 111 (10), 5078-5085, 2008
5172008
Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value
S Abbas, S Lugthart, FG Kavelaars, A Schelen, JE Koenders, ...
Blood, The Journal of the American Society of Hematology 116 (12), 2122-2126, 2010
4932010
Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further …
E Taskesen, L Bullinger, A Corbacioglu, MA Sanders, CAJ Erpelinck, ...
Blood, The Journal of the American Society of Hematology 117 (8), 2469-2475, 2011
4452011
Incidence and prognosis of c‐KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias
RS Care, PJM Valk, AC Goodeve, FM Abu‐Duhier, ...
British journal of haematology 121 (5), 775-777, 2003
4142003
Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling
RGW Verhaak, BJ Wouters, CAJ Erpelinck, S Abbas, HB Beverloo, ...
haematologica 94 (1), 131, 2009
3822009
Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia
S Li, FE Garrett-Bakelman, SS Chung, MA Sanders, T Hricik, F Rapaport, ...
Nature medicine 22 (7), 792-799, 2016
3802016
High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients
S Barjesteh van Waalwijk van Doorn-Khosrovani, C Erpelinck, ...
Blood, The Journal of the American Society of Hematology 101 (3), 837-845, 2003
3712003
Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival
H Hock, E Meade, S Medeiros, JW Schindler, PJM Valk, Y Fujiwara, ...
Genes & development 18 (19), 2336-2341, 2004
3662004
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
M Heuser, SD Freeman, GJ Ossenkoppele, F Buccisano, CS Hourigan, ...
Blood, The Journal of the American Society of Hematology 138 (26), 2753-2767, 2021
3582021
High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated
S Lugthart, E van Drunen, Y van Norden, A van Hoven, CAJ Erpelinck, ...
Blood, The Journal of the American Society of Hematology 111 (8), 4329-4337, 2008
3462008
The system can't perform the operation now. Try again later.
Articles 1–20